Maniza Muni

Maniza Muni

Auto-generated profile, based on publicly available information

Maniza Muni

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
JAJuhaer Anjum
Juhaer Anjum
MMManiza Muni
Maniza Muni
NSNusrat Jahan Shawon
Nusrat Jahan Shawon
FAFahima Aktar
Fahima Aktar
MHMehadi Hasan
Mehadi Hasan
MAMd. Shah Amran
Md. Shah Amran
The search for antidiabetic drugs from natural sources has been carried out since diabetes has become a prevalent chronic disease, whose conventional therapy causes several complications in long-term use. Gynura procumbens (GP), a well-known herb for its various activities, has shown promising results against diabetes in several studies. To find whether the mechanism of activity behind this antidiabetic effect is underpinned by the upregulation of a particular glucose transporter (GLUT-4), this experiment was conducted. The GLUT-4 expression levels in Alloxan-induced diabetic rats were compared with untreated healthy rats and rats treated with different doses of G. procumbens extract using enzyme-linked immunosorbent assay (ELISA) specified for rat GLUT-4. All four test groups including the metformin control group showed elevated expression of GLUT-4 in the liver tissue compared to the diabetic control group (p < 0.05, one-way ANOVA). The serum-glucose modulatory antidiabetic activity of ethanolic extract of G. procumbens was therefore mediated though the upregulation of GLUT-4 expression, and consequent increased uptake of glucose.

31 December 2024 in Avicenna Journal of Medical Biochemistry
Verified
Journal Article
Open access
PDF file
MMManiza Muni
Maniza Muni
MMMst. Morsheda Akter Mim
Mst. Morsheda Akter Mim
FAFahima Aktar
Fahima Aktar
SASyeda Sadia Afrin
Syeda Sadia Afrin
SASafaet Alam
Safaet Alam
MAMd. Shah Amran
Md. Shah Amran
Background: Diabetes is the most common chronic disease worldwide, requiring lifelong medication support. As conventional medications have numerous long-term side effects, herbal drugs, which offer similar effectiveness but fewer complications, are considered an alternative. A common tropical herb, Eclipta prostrata, was tested for its antidiabetic activities. Objectives: The principal objective of this study was to investigate the antidiabetic efficacy of E. prostrata extract using in silico, in vitro, and in vivo methods. Methods: The in silico study comprised ligand library preparation through a literature review, structure optimization using Avogadro software and molecular docking against five antidiabetic macromolecules using PyRx. The in vitro alpha-amylase inhibitory study was conducted using the dried extract of E. prostrata. The in vivo study was performed on alloxan monohydrate-induced diabetic rats at a dose of 150 mg/kg, followed by treatment with three doses of 70% ethanolic extract of the whole plant (250 mg/kg, 500 mg/kg, and 750 mg/kg) for 28 days. Then, plasma glucose levels, plasma glucagon-like peptide-1 (GLP-1) levels, and histopathological assays of rat livers were carried out. Results: The in silico studies helped screen out the most effective antidiabetic constituents of E. prostrata, which may serve as lead compounds for developing antidiabetic drugs in the future. The IC50 value for E. prostrata extract was 22.21 mg/mL in the alpha-amylase assay. The plant extract significantly improved the health of the diabetes-induced rats. Conclusion: Based on these findings, E. prostrata could be an effective natural antidiabetic drug.